The trademark application NeuroAirmid was filed by NeuroAirmid Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 5, 2022, and it was registered by office on September 12, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances and pharmaceutical preparations and human therapeutic preparations for treating and preventing neurological diseases, disorders and conditions..
The mark was filed in class 42 with following description of goods:
Development of pharmaceutical preparations and medicines
Medical and scientific research in the areas of medicines and pharmaceuticals
Research and development of pharmaceuticals for treating and preventing neurological diseases, disorders and conditions
Providing scientific research information in the fields of pharmaceuticals, therapies, and neurological diseases.